Pediatrics Articles

Pediatrics

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Donnithorne KJ et al. - To report on the efficacy of rituximab (RTX) therapy in standard treatment-refractory, chronic Henoch-Schonlein purpura, a retrospective chart review of 3 pediatric patients treated with RTX for severe refractory chronic Henoch-Schonlein purpura was performed. All 3 patients responded to 1 or 2 courses of RTX without serious adverse events.

Related Articles

Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura
International Journal of Hematology, 10/12/09    Relevance Score: 45%

A purpuric rash
Australian Family Physician, 11/09/09    Relevance Score: 44%

Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09    Relevance Score: 43%

Immune thrombocytopenia associated with Mycoplasma pneumoniae infection: a case report and review of literature
Blood Coagulation & Fibrinolysis, 10/07/09    Relevance Score: 43%

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
Blood, 10/02/09    Relevance Score: 43%